| Financial Year |
March 31 2023 |
| Monetary Funds |
265,962,114.21 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
76,387,157.98 |
| Accounts Receivable |
187,692,441.28 |
| Advances to Suppliers |
16,196,110.34 |
| Other Receivables |
3,577,805.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
324,945,687.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
542,720.43 |
| Total Current Assets |
963,719,308.41 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
22,281,193.68 |
| Investment Properties |
35,990,853.93 |
| Fixed Assetes |
840,416,114.33 |
| Under-construction Projects |
173,695,133.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
150,273,046.36 |
| R&D expenses |
2,035,433.96 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,363,106.93 |
| Deferred Income Tax Assets |
11,791,169.17 |
| Other Non-Current Assets |
37,605,619.30 |
| Sub-Total of Non-Current Assets |
1,282,073,165.95 |
| Total Assets |
2,245,792,474.36 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,278,117.80 |
| Accounts Payable |
97,949,094.31 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,561,036.35 |
| Taxes Payable |
19,503,869.54 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,048,049.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
30,316,881.68 |
| Other Current Liabilities |
53,465,588.02 |
| Sub-Total of Current Liabilities |
256,109,291.89 |
| Long-term Loans |
116,330,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
10,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
25,198,358.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
198,941,078.80 |
| Total Liabilities |
455,050,370.69 |
| Paid-In Capital(Or Share Stock) |
593,602,983.00 |
| Capital Surplus |
635,820,853.58 |
| Surplus Reserve |
47,560,682.43 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
282,662,155.75 |
| Minority Stockholder's Interest |
231,095,428.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,559,646,674.76 |
| Owner's Equity（Stockholder's Equity） |
1,790,742,103.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,245,792,474.36 |
